Date | Time | Source | Headline | Symbol | Company |
05/28/2024 | 12:04PM | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NASDAQ:SNY | Sanofi |
05/28/2024 | 10:34AM | Edgar (US Regulatory) | Form SD - Specialized disclosure report | NASDAQ:SNY | Sanofi |
05/23/2024 | 7:40AM | IH Market News | OpenAI and News Corp Seal Partnership, DuPont de Nemours Announces Division, and More News | NASDAQ:SNY | Sanofi |
05/21/2024 | 7:18AM | IH Market News | CalPERS to Oppose Exxon Mobil Directors; Microsoft Unveils Copilot+ PCs with AI Focus, and More News | NASDAQ:SNY | Sanofi |
05/13/2024 | 1:00AM | GlobeNewswire Inc. | Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP) | NASDAQ:SNY | Sanofi |
05/10/2024 | 8:02AM | IH Market News | Novavax Surges 57% Post $1.4 Billion Sanofi Deal; Apple Boosts Data Centers with AI and Internal Chips, and More News | NASDAQ:SNY | Sanofi |
05/10/2024 | 2:00AM | PR Newswire (US) | Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination Vaccines | NASDAQ:SNY | Sanofi |
04/25/2024 | 7:52AM | IH Market News | Southwest Shares Tumble 9.6% Post $231 Million 1Q Loss, AstraZeneca Surges on 19% Annual Increase, and More on Earnings | NASDAQ:SNY | Sanofi |
04/19/2024 | 7:31AM | IH Market News | Paramount’s Shares Surge Following Sony and Apollo’s Joint Bid; ISS Backs Berkshire Hathaway Director Re-election, and More | NASDAQ:SNY | Sanofi |
02/23/2024 | 2:02PM | Edgar (US Regulatory) | Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)). | NASDAQ:SNY | Sanofi |
02/23/2024 | 11:15AM | Edgar (US Regulatory) | Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | NASDAQ:SNY | Sanofi |
02/15/2024 | 12:09PM | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NASDAQ:SNY | Sanofi |
02/14/2024 | 3:57PM | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:SNY | Sanofi |
01/25/2024 | 2:29PM | GlobeNewswire Inc. | Dupixent® (dupilumab) FDA Approved as First and Only Treatment Indicated for Children Aged 1 Year and Older with Eosinophilic Esophagitis (EoE) | NASDAQ:SNY | Sanofi |
01/23/2024 | 7:23AM | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NASDAQ:SNY | Sanofi |
01/23/2024 | 6:05AM | Dow Jones News | Sanofi to Buy Assets From Inhibrx in Deal Valued at Up to $2.2 Billion -- Update | NASDAQ:SNY | Sanofi |
01/23/2024 | 5:40AM | IH Market News | Wall Street Highlights: Vroom Shuts Down Online Car Sales, Ericsson Warns of Decline Outside China, and More | NASDAQ:SNY | Sanofi |
01/23/2024 | 1:00AM | PR Newswire (US) | Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B | NASDAQ:SNY | Sanofi |
01/17/2024 | 1:49PM | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NASDAQ:SNY | Sanofi |
01/09/2024 | 2:14AM | Dow Jones News | Sanofi Names Brian Foard Head of Specialty-Care Unit | NASDAQ:SNY | Sanofi |
12/27/2023 | 11:18AM | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NASDAQ:SNY | Sanofi |
12/21/2023 | 2:25AM | Dow Jones News | Sanofi Ends Drug Program After Late-Stage Trial in Lung Cancer Fails | NASDAQ:SNY | Sanofi |
12/19/2023 | 7:28AM | Dow Jones News | Innate Pharma Shares Rise after Sanofi Exercises Licensing Option | NASDAQ:SNY | Sanofi |
12/12/2023 | 5:50AM | IH Market News | Hasbro Job Cuts, Oracle’s Stock Decline, Google’s Epic Antitrust Loss, and More | NASDAQ:SNY | Sanofi |
12/11/2023 | 5:18PM | Dow Jones News | Sanofi Terminates Agreement with Maze Therapeutics Following FTC Opposition | NASDAQ:SNY | Sanofi |
12/11/2023 | 1:50AM | Dow Jones News | Sanofi Sees Improvement in Trial Results of Cancer Drug Sarclisa | NASDAQ:SNY | Sanofi |
12/07/2023 | 2:34AM | Dow Jones News | Sanofi Myeloma Drug Sarclisa Met Primary Goal in Late-Stage Trial | NASDAQ:SNY | Sanofi |
12/07/2023 | 2:20AM | Dow Jones News | Sanofi Sees Annual Sales From New Pharma Assets Above $10.8 Billion by 2030 | NASDAQ:SNY | Sanofi |
12/06/2023 | 8:20AM | Dow Jones News | Trending: Merck's Multiple Sclerosis Drug Misses Expectations in Late-Stage Trials | NASDAQ:SNY | Sanofi |
12/06/2023 | 5:14AM | Dow Jones News | Merck Shares Slump After Multiple Sclerosis Drug Fails in Late-Stage Trials | NASDAQ:SNY | Sanofi |